Opinions from the Office of Legal Counsel (OLC) are not typically of much interest to private employers. (You may or may not have even heard of the OLC). After all, the Office’s role is to advise the Executive branch. However, a recently released OLC opinion addresses a question preying on many minds: Is it lawful for employers to mandate a COVID-19 vaccine even when the vaccine has not received full approval from the Food and Drug Administration, the federal agency responsible for the safety and efficacy of vaccines?

Without much fanfare, the OLC decided to tackle this question head-on. Whether Section 564 of the Food, Drug, and Cosmetic Act Prohibits Entities from Requiring the Use of a Vaccine Subject to an Emergency Use Authorization. Specifically, the OLC opinion explores the question of whether the current Emergency Use Authorization (EUA) status of the COVID-19 vaccines would preclude public or private entities from mandating those vaccines. OLC concludes that it does not.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]